Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PEX5L | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ATAT1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | KARS | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | ZNF443 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CTD-3105H18.18 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | C3orf70 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | ZNF100 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | EBF1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | POLR3C | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | GPR173 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |